Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Assets (2018 - 2025)

Historic Assets for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $61.6 million.

  • Bio's Assets rose 1616.68% to $61.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.6 million, marking a year-over-year increase of 1616.68%. This contributed to the annual value of $86.6 million for FY2024, which is 1091.89% up from last year.
  • Latest data reveals that Bio reported Assets of $61.6 million as of Q3 2025, which was up 1616.68% from $67.5 million recorded in Q2 2025.
  • Over the past 5 years, Bio's Assets peaked at $94.4 million during Q2 2023, and registered a low of $51.3 million during Q2 2022.
  • Moreover, its 5-year median value for Assets was $68.8 million (2021), whereas its average is $70.2 million.
  • Its Assets has fluctuated over the past 5 years, first surged by 8387.0% in 2023, then tumbled by 3928.33% in 2024.
  • Quarter analysis of 5 years shows Bio's Assets stood at $62.5 million in 2021, then increased by 8.49% to $67.9 million in 2022, then increased by 15.02% to $78.0 million in 2023, then increased by 10.92% to $86.6 million in 2024, then decreased by 28.86% to $61.6 million in 2025.
  • Its last three reported values are $61.6 million in Q3 2025, $67.5 million for Q2 2025, and $77.3 million during Q1 2025.